These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting. Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894 [TBL] [Abstract][Full Text] [Related]
3. Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting. Beiras-Fernandez A; Kowert A; Jiru P; Weis M; Spannagl M; Reichart B; Schmoeckel M Ann Thorac Surg; 2009 Feb; 87(2):629-31. PubMed ID: 19161801 [TBL] [Abstract][Full Text] [Related]
4. Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery. Cheng DK; Jackevicius CA; Seidelin P; Feindel C; Rouleau JL Can J Cardiol; 2004 Feb; 20(2):223-8. PubMed ID: 15010747 [TBL] [Abstract][Full Text] [Related]
5. Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events. Dunkley S; Evans S; Gaudry L; Jepson N Platelets; 2005 Dec; 16(8):462-8. PubMed ID: 16287613 [TBL] [Abstract][Full Text] [Related]
9. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes. Harrington RA Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670 [TBL] [Abstract][Full Text] [Related]
10. Practical approach to the diagnosis and management of thrombocytopenia associated with tirofiban treatment. Mulot A; Moulin F; Fohlen-Walter A; Angioi M; Sghaier M; Carteaux JP; Lecompte T; de Maistre E Am J Hematol; 2004 Sep; 77(1):67-71. PubMed ID: 15307109 [TBL] [Abstract][Full Text] [Related]
11. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes. Bolognese L Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721 [TBL] [Abstract][Full Text] [Related]
12. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439 [TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade. Durand M; Lecompte T; Hacquard M; Carteaux JP Eur J Cardiothorac Surg; 2008 Sep; 34(3):687-9. PubMed ID: 18579401 [TBL] [Abstract][Full Text] [Related]
15. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction. Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139 [TBL] [Abstract][Full Text] [Related]
16. Glycoprotein IIb-IIIa inhibitors in the emergency department for patients with non-ST-elevation acute coronary syndromes: principles and practices. Lefebvre CW; Hoekstra JW; Bonaca M; Giugliano R J Emerg Med; 2009 Feb; 36(2):162-70. PubMed ID: 18353601 [TBL] [Abstract][Full Text] [Related]